These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16731022)

  • 41. Extradural motor cortex stimulation in Parkinson's disease.
    Cilia R; Landi A; Vergani F; Sganzerla E; Pezzoli G; Antonini A
    Mov Disord; 2007 Jan; 22(1):111-4. PubMed ID: 17083104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Globus pallidus stimulation in advanced Parkinson's disease.
    Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
    J Clin Neurosci; 2007 Mar; 14(3):208-15. PubMed ID: 17150360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
    Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
    Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pain in Parkinson's disease.
    Ford B
    Mov Disord; 2010; 25 Suppl 1():S98-103. PubMed ID: 20187254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease.
    Suzuki K; Miyamoto M; Miyamoto T; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
    Parkinsonism Relat Disord; 2009 Jan; 15(1):15-9. PubMed ID: 18359262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
    Hauser RA; McDermott MP; Messing S
    Arch Neurol; 2006 Dec; 63(12):1756-60. PubMed ID: 17172616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor.
    Miller KM; Okun MS; Fernandez HF; Jacobson CE; Rodriguez RL; Bowers D
    Mov Disord; 2007 Apr; 22(5):666-72. PubMed ID: 17266084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zolpidem improves akinesia, dystonia and dyskinesia in advanced Parkinson's disease.
    Chen YY; Sy HN; Wu SL
    J Clin Neurosci; 2008 Aug; 15(8):955-6. PubMed ID: 18485713
    [No Abstract]   [Full Text] [Related]  

  • 53. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
    Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease.
    Tabbal SD; Revilla FJ; Mink JW; Schneider-Gibson P; Wernle AR; de Erausquin GA; Perlmutter JS; Rich KM; Dowling JL
    Neurosurgery; 2007 Sep; 61(3 Suppl):119-27; discussion 127-9. PubMed ID: 17876242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.
    Kulisevsky J; Pascual-Sedano B; Barbanoj M; Gironell A; Pagonabarraga J; García-Sánchez C
    Mov Disord; 2007 Jan; 22(1):62-7. PubMed ID: 17115388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case of Parkinson's disease following dystonia].
    Yasuda C; Takei T; Uozumi T; Toyota T; Yuhi T; Adachi H
    Rinsho Shinkeigaku; 2016 Sep; 56(9):600-4. PubMed ID: 27498816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.